Pulmonary Fibrosis

---

Interstitial lung disease and IPF 

Interstitial lung disease is a group of disorders characterized by lung inflammation and thick, stiff, or scarred lungs. Such lung fibrosis causes breathing difficulties  and reduced oxygen intake into the bloodstream. Interstitial lung  disease includes hypersensitivity pneumonitis and idiopathic pulmonary fibrosis.  

1) Hypersensitivity Pneumonitis  Hypersensitivity pneumonitis is lung inflammation due to inhaled hazardous materials such as asbestos, silicon dust or coal dust, smoking, bacteria, fungus, molds, mycobacteria, or chemicals. Blood-born toxins, medications or drugs, and radiation can also be the cause. When these toxic substances are initially exposed, they may not cause noticeable problems. However, after a large dose of exposure or repeated exposure, it can cause alveolar inflammation called alveolitis. The alveolar walls may be filled with white blood cells or with fluid in some cases. Patients may start to develop symptoms including dry cough, shortness of breath, chest tightness, fever, chills, and tiredness. 

Hypersensitivity pneumonitis is completely reversible in the early stages. If the person is no longer exposed to these toxins, the inflammation and resulting symptoms will get better within a few days as the injury to the lung is repaired naturally by the body. However, if a person's lungs are repeatedly exposed to these toxic substances, the air sacs of the lung will be continuously injured and the repair process 

continues. Ordinarily, our body generates just the right amount of tissue to repair damage. However, in some individuals such   Damaging Agents

repeated injury may trigger an abnormal healing responses in  

which the repair process goes awry and the tissue around the air sacs becomes scarred and thickened, and pulmonary fibrosis can occur. 

In such abnormal healing responses, injury to the alveoli activates macrophages to release pro-fibrotic factors such as tumor necrosis factor alpha (TNF-a) and transforming growth factor beta (TFG-β) which attract fibroblasts and stimulate their proliferation causing scar formation. Such repair processes will further stimulate pneumocytes to secrete chemotactic factors to attract additional macrophages to the alveolar milium leading to parenchymal injury and proliferation of fibroblasts causing the development and progression of interstitial pulmonary fibrosis. Patients will start to have trouble breathing with symptoms of shortness of breath at rest or with activity, dry cough, and unintentional weight loss. 

Once lung scarring occurs, it is irreversible and the condition will become progressively worse. Chest X-rays will show diffuse infiltration by small nodules, irregular lines, or “ground-glass shadows”. The end stage of the condition is diffuse infiltration pulmonary fibrosis. Patients will not get enough oxygen even with oxygen support and will suffer from respiratory failure. Patients will develop complications with pulmonary hypertension and enlargement of the right ventricle of the heart which can result in peripheral edema. A lung transplant will be recommended as an option. 

2) Idiopathic pulmonary fibrosis (IPF) 

Comparing to the pulmonary fibrosis caused by hypersensitivity pneumonitis, idiopathic pulmonary fibrosis (IPF) occurs when scarring or fibrosis of the lungs occurs due to an unknown reason. It is characterized by patchy lung fibrosis and formation of cystic spaces. Scarring typically starts at the edges and progresses towards the center of the lungs. Patients usually develop symptoms of shortness of breath and a dry cough. As the condition progresses, patients will need oxygen support and can suffer from respiratory failure. Late stage IPF patients will also develop complications with pulmonary hypertension and enlargement of the right ventricle of the heart which can result in peripheral edema. The progression of IPF is relentless despite therapy, and the mean survival is 3 years or less. 

Intensive research has been conducted to find what causes IPF. It has been found that IPF is strongly associated with gastroesophageal reflux disease (GERD), a condition where stomach acid flows back into the esophagus. It's estimated that 90 percent of people with IPF have GERD. There are many theories about the connection of IPF with GERD and researchers are investigating whether aspiration of stomach acid is the cause of IPF or it causes the acute episodes and worsening of the lung scarring. Recent studies have found that treating people who have IPF for GERD is beneficial. 

A 2011 study found that people with IPF who used GERD medication had median survival rates about twice as long as those patients who didn’t use the medication. Also, there was less lung scarring. A small 2013 study of patients with IPF found that those taking GERD medication had a slower decline in their breathing capability and fewer acute episodes and the authors suggest that GERD is a contributing factor in IPF. 

Viral infections have also long been known to be a risk factor for development of IPF. These viruses include EpsteinBarr virus,influenza A virus, hepatitis C virus, HIV, and human herpesvirus. Accumulating research results suggests that infections may be the initiators and exacerbating agents. One or more of the herpes viruses’ DNA including cytomegalovirus (CMV), herpesvirus-5 (HHV-5), Epstein-Barr virus (EBV), human herpesvirus-7 (HHV-7), and HHV-8 were consistently detected in lungs of patients with IPF. The presence of herpes viral DNA and epithelial cell stress found in the lungs of IPF patients and additional research has demonstrated that preceding viral infections appear to reprogram lung epithelial cells during latency to produce pro-fibrotic factors, making the lung susceptible to subsequent fibrotic insult. Whereas, active viral replication later on or other acute viral infections such as from the cold or flu cause exacerbations of existing fibrosis with rapid fibrotic tissue formation. 

Progression of Interstitial Lung Disease and IPF 

Interstitial lung disease including IPF is a progressive and life-threatening lung disease. Although it has an overall poor prognosis, the clinical course of individual patients 

varies  from 

slow progression to  acute decomposition and death. Patient's life expectancy can be over ten years from the onset of symptoms if their condition  is  in  slow progressive  course. 

However, if their condition is in rapid progressive course, their life expectancy can be as short as three years. Acute exacerbations are the main  accelerator  of  the disease progression. 

Complications 

Lung fibrosis can lead to a series of life-threatening complications, including pulmonary hypertension and rightsided heart failure or cor pulmonale. Unlike systemic high blood pressure, pulmonary hypertension affects only the arteries in the lungs. It begins when scar tissue restricts the smallest blood vessels, limiting blood flow through the lungs. This in turn raises pressure within the pulmonary arteries. Pulmonary hypertension is a serious illness that becomes progressively worse. 

Right-sided heart failure occurs when the heart's lower right chamber (right ventricle) which is less muscular than the left has to pump harder than usual to move blood through obstructed pulmonary arteries. Eventually the right ventricle fails from the extra strain which can result in peripheral edema. This is often a consequence of pulmonary hypertension. 

Wellness Recommendation 

The recommendation for interstitial pulmonary fibrosis and IPF includes Soup A, Soup B, and LC Balancer. Soup A helps to complete the lung injury repair process and terminate the vicious cycle of repairing, more damage, and fibrosis formation by increasing the metabolic activities of healthy lung tissue regeneration, known as Lung Yin nurturing in TCM. Soup A helps increase the biosynthesis of proteins, DNA, and mRNA, etc. as well as the supply of building blocks including amino acids, carbohydrates, and other cofactors necessary to speed up healthy new tissue growth of the alveoli and bronchioles. Soup B helps remove nodules and dissolve the lung scarring and fibrotic tissues by triggering the necessary catabolic processes and enhancing the body’s endogenous enzymatic activities toward scar removal. LC Balancer improves microcirculation to help nutrient supply and waste removal from the lung tissue. Patients usually experience improvement in their breathing with decreased fatigue within 2-4 weeks of the combined protocol 

Early Stage: 

Soup A, Soup B, and LC Balancer are able to resolve the lung fibrosis condition to help regain normal breathing in 1-3 months for patients with early stage condition and are not on oxygen therapy. 

Late Stage: 

Soup A, Soup B, and LC Balancer are recommended for 3-6 months for late-stage cases and patients require use of oxygen. After patients have achieved a significant improvement in their breathing and are either off oxygen or use less oxygen, a continuous maintenance dose is recommended. Soup A, Soup B, and LC Balancer at one-third to one-half dose are required to use continuously. 

End Stage: 

Soup A, Soup B, and LC Balancer can help stop the fast deterioration of the lung structure in 3-6 months for end stage cases which require oxygen 24/7. A continued treatment of 6 months may be required to experience symptom improvement. Over 9 months of treatment may be required to achieve significant symptom improvement and/or better quality of life. An additional formula may be required depending on complications. A continuous maintenance dose is recommended after the full protocol. Soup A, Soup B and LC Balancer at one-third to one-half dose are required to use continuously. 

End Stage with Rapid Progression Course: 

If patients are in the end stage condition with rapid progressive course, some of them may not experience quick symptom improvement with the use of Soup A, Soup B, and LC Balancer. However, the protocol is able to either hold the rapid progression or change the course of progression from rapid progression to slow progression during the initial 3-6 months. A continued treatment of 9 months may be required to experience symptom improvement. Over 12 months of treatment may be required to achieve significant symptom improvement and/or better quality of life. An additional formula may be required depending on complications. A continuous maintenance dose is recommended after the full protocol. Soup A, Soup B, and LC Balancer at one-third to one-half dose are required to use continuously. 

Dissolving Lung Scars 

Chronic lung inflammation due to infections or toxins can cause scar tissue formation which may contain embedded pathogens or toxins. Soup B helps break down and dissolve the scar tissue. As the scar tissue is dissolved, the embedded pathogens or toxins can be released and start to proliferate which can cause symptoms of chest heaviness, tightness, difficulty breathing, low-grade fever, and flu like symptoms. The pathogens and toxins can also get into the blood which flow back to the heart causing heart irritation with symptoms of a heart murmur, chest pain, and difficulty breathing. If patients experience these symptoms after the use of Soup B, they should be evaluated for further treatment depending on the type of pathogens or toxins. 

Maintenance Recommendation: 

Wei Laboratories herbal formulations are not a permanent solution for patients with a late or end-stage conditions. The purpose is to get patients to their goal of a normal lifestyle and to maintain their lung health. The continuous maintenance dose will also help to prevent the progression of the condition as well as prevent acute exacerbations or flare-ups and emergency room visits. 

Additional Recommendations: 

Complications such as congestive heart failure can be caused by the lung fibrotic condition. However, many complications such as infection, acid reflux, and poor liver/kidney health can be the cause of lung fibrosis. If the patient did not respond well to the Soup A, Soup B and LC Balancer treatment in 2-4 weeks, additional formulas are required depending on the type of complication. If patients are responding well, however, additional treatments are also highly recommended to eliminate the cause of the lung fibrosis. 

a) Lung Inflammation: Chronic lung inflammation increases the risk of developing lung fibrosis. For patients with lung inflammation, ClearLung is recommended to use together with the Soup A, Soup B, and LC Balancer. During the cold and flu season, it is recommended to have ClearLung and Jade on hand to take immediately upon the onset of symptoms such as colored phlegm and mucus to help clear the virus. Jade boosts Lung Qi and enhances lung immunity to help eliminate viruses. The combined protocol helps patients go through the flu and cold season with less possible triggers of acute exacerbation by the flu virus. For lung inflammation caused by acute gram-positive bacterial infections, ClearLung in combination with Bitter, Brown, Qi Booster and LC Balancer is required. 

b) Congestive Heart Failure and Lower Extremity Edema: Pulmonary fibrosis can cause right-sided heart failure with symptoms of lower extremity edema. Congestive heart failure also causes shortness of breath. Patients may take diuretics such as Lasix to get rid of ankle swelling by pushing the kidney to expel more water. However, diuretics do not help breathing. Java is recommended to improve lymphatic circulation to lower the burden on the heart and improve the heart failure condition for better breathing. Patients should experience improvement in their breathing and water retention in 1-2 weeks. Longer periods of treatment may be required depending on the severity of the condition. Left-side congestive heart failure is not related to lung condition and is usually caused by heart attack, hypertension, mitral or aortic valve disease, and primary myocarditis. Myogen, CV, B-2 and Qi Booster are required for such conditions. 

c) Chronic Viral Infections: Viral infection can potentially cause IPF. For patients with persistent chronic viral infections in the lungs, initial recommendations include ClearLung and Jade for 3-4 weeks. ClearLung helps clear the virus that is floating in the extracellular space of the lung tissue. Jade helps enhance the lung immunity to further clear the extracellular viruses. If the virus is not just confined in the lungs, Woad in combination with Bitter, Brown, Qi Booster and LC Balancer may also be required for 3-4 weeks. Woad helps clear extracellular virus floating in the blood and other area of the body. Bitter, Brown, Qi Booster and LC Balancer helps enhance the immunity of the whole body. 

The second step of the recommendation is to clear the viral infected cells in the lungs using Perilla with Brown, LC Balancer, and Xcel for 4-8 weeks. Perilla helps enhance cellular immunity of the lungs to clear the virus infected cells in the lung. Brown, LC Balancer, and Xcel help support the liver and kidney for effective waste removal. For persistent chronic viral infection in other areas of the body additional viral formulas are required. Please refer to the Viral Infection Protocol for details. 

d) Other Chronic Lung Infections: Besides for viruses, slow growth microbial including gram-negative bacteria, mycobacteria such as mycoplasma pneumonia or Mycobacterium avium complex (MAC), fungus, and parasitic microorganisms such as Pneumocystis jiroveci can also cause chronic lung infections. These infections can also trigger inflammatory responses in the lung which may cause the accelerated progression of lung fibrosis. Symptoms of mycobacterial infection include post-nasal drip, nasal congestion, excessive phlegm production, and a hoarse voice in addition to typical respiratory symptoms. The recommended protocol for mycobacteria includes Java, Jade, ClearLung, and NewBase.  

Patients with a mycobacterial infection usually have coinfection of gram-negative bacteria. Mycobacteria is able to inhibit the normal microbicidal response causing impairment of effective phagolysosome formation. The suppression of immune function favors mycobacterial proliferation and harboring of other slow-growth gramnegative bacteria. CL-2 is recommended to clear gram-negative bacterium in the lung. If the nasal passage is also infected by gram-negative bacteria, Rhinocin is also required. 

Lung fungal infections are another type of chronic lung infections. Patients usually experience symptoms of difficulty inhaling air into the lungs, and chest tightness, especially upon exertion. CL-F is recommended to clear fungal infection by removing Lung Heat Toxins. If patient’s nasal passage is also infected by the fungus, Wave and/or Wave-2 are required. 

Parasitic infections are another type of chronic lung infections caused by parasitic microorganisms such as Pneumocystis jiroveci. Lung parasite infections can cause symptoms of pulmonary hypertension such as shortness of breath and chest pressure. Other non-respiratory symptoms include heart palpitations, dizziness, fatigue, and water retention. Pulmin with Respanin are recommended for lung parasite infections. Pulmin helps clear the infection and Respanin helps clear the die-off effect and the irritation to the pulmonary blood vessels from the parasite toxins. Patients may develop symptoms of acute infections as the immune system starts to attack the bacteria. Treatment with Bitter, Brown, Qi Booster, and LC Balancer are recommended to assist the immune system to clear the bacteria from the respiratory tract. 

e) GERD: Acid reflux can cause irritation and injury to the alveoli and bronchi when the acid gets into the lungs during sleep triggering alveolitis. The use of acid blockers and proton pump inhibitors can cause poor digestion resulting in poor absorption of nutrients as well as the herbal ingredients. Patients may complain of stomach irritation with less optimal treatment results with the use of Soup A, Soup B and LC Balancer. Spring, SJ, and Formula B are recommended to resolve the acid reflux and improve digestion and nutrient absorption. 

f) Liver and Kidney (Adrenal) Deficiencies: Poor liver and kidney function can cause slowed metabolic toxin processing. Many metabolic toxins have to be modified by the liver or kidney oxygenases to oxidize them by adding –OH or =O groups, or by methylation enzymes to add –CH3groups, so that the kidneys can secrete them out. If these toxic compounds are processed too slowly by the liver and kidneys, or the kidneys can’t secrete them promptly after being modified, the toxic waste molecules can be accumulated at high concentrations in the blood. As water is evaporating from the lungs as we breath, these toxic compounds can be condensed in the lung and cause irritation to lung tissue triggering alveoli inflammation. Symptoms of a liver deficiency include anxiety, difficulty falling asleep, headache, nausea, abdominal fullness, mood swings, or bad temperament. Symptoms of kidney deficiency include low energy, difficulty staying asleep, water retention, flu-like symptoms, or high blood pressure. Brown is recommended to nurture the liver and improve liver function and Xcel is recommended to improve kidney function. 

g) Pulmonary Hypertension: Pulmonary fibrosis can lead to pulmonary hypertension when scar tissue restricts the blood vessels. As the scar tissue is being dissolved, the increased blood pressure in the lungs should be improved. However, other conditions such as a lung parasitic infection can also cause pulmonary hypertension. Recommendation for parasitic microorganisms in the lungs includes Pulmin and Respanin. Pulmin helps clear 

the lung parasite infection. Respanin helps clear the die-off effect and irritation of the pulmonary blood vessel by the parasite toxins. 

h) Asthma: Asthma is the chronic inflammation of the airway that causes recurrent episodes of wheezing, breathlessness, chest tightness and cough, particularly at night and/or early in the morning. It is caused by airway hypersensitivity and intermittent airway obstruction due to chronic bronchial inflammation involving eosinophils infiltration and bronchial smooth muscle cell hypertrophy and hyper-reactivity. The irritants can be external (atopic) such as pollen, or internal (non-atopic) such as the body’s own metabolic toxins or infection. These irritants and the resulting airway inflammation may also be the trigger of the alveolitis. Recommended treatments include EzAir or Breez to reduce airway sensitivity and clear Liver Wind, in TCM terms. EzAir is for atopic asthma. Breez is for non-atopic asthma. Patients should have a significant improvement in 1 week. A longer period of treatment is required depending on the severity of the condition. For non-atopic asthma caused by chronic infections, additional treatments are also required as described in the protocol. 

Complications 

Additional   Recommendations 

Lung Inflammation 

ClearLung 

Congestive Heart Failure & Lower Extremity 

Edema 

Java and/or 

Myogen, CV, B-2 and Qi Booster 

Acute Lung Infection 

ClearLung, Bitter, Brown, Qi Booster and LC Balancer 

Cold or Flu, Acute Viral Infections 

ClearLung, Jade, Woad 

Chronic Viral Infections 

Perilla, Brown, LC Balancer, and Xcel 

Mycobacterial Infections 

Java, Jade, ClearLung and NewBase 

Lung Gram Negative Bacterial Infections 

CL-2 

Lung Fungal Infections 

CL-F 

GERD, Acid Reflux 

Spring, SJ and Formula B 

Liver Deficiency 

Brown 

Kidney Deficiency (Adrenal Deficiency) 

Xcel 

Lung Parasite Infections / Pulmonary 

Hypertension 

Pulmin and Respanin 

Asthma 

EZAir and/or Breez 

Selected Case Studies: 

Case 1: Reversal of COPD and Lung Fibrosis with Chest X-Ray 

Before Treatment After Treatment 

A 68-year- old female diagnosed with COPD and pulmonary fibrosis treated with Soup A, Soup B and LC Balancer for 1 month. 

Chest X-ray PA/LAT (2VW) - (ADX/0022) Pre-treatment diagnosis on 2/3/2006: 

“Moderate pectus deformity. COPD with scattered fibrosis” Post-treatment diagnosis on 8/24/2006: 

“No active cardiopulmonary disease” 

After 2 weeks of treatment, the patient noticed 80% reduction in shortness of breath. After 1 month, the patient reported symptoms 95-98% elimination and was able to exercise regularly.  Post-treatment chest X-ray shows no sign of COPD or fibrosis, indicating a complete reversal of COPD and lung fibrosis. 

Case 2: Improvement in Symptoms and Reduction in Oxygen Dependency in IPF Patient 

A 77-year-old male presented with shortness of breath and violent dry coughs throughout the day due to Pulmonary Fibrosis. The patient was diagnosed with Pulmonary Fibrosis in early 2018 through MRI scans after complaints of getting out of breath for over a year. The patient also had constant sinus drainage and even though his physician found no known allergies, the doctor still concluded he was allergic to something. The patient was also diagnosed with High Blood Pressure, High Cholesterol, and a Thyroid Disorder. He was on oxygen 24/7. 

After evaluation, Dr. put the patient on Soup A, Soup B, LC Balancer in February 2018 to provide necessary nutrients to help repair the lung structure and enhance its function. The patient has been on the protocol for 6 months (currently Aug 2018). ClearLung was added as needed to clear out gram-positive bacteria, and inflammation in his lungs and to reduce his coughing bouts. In March, the patient reported seeing improvement from his dry to wet cough with more productive coughing with phlegm. In May, the patient reported only needing to use oxygen 50% of the time while his phlegm was light brown in the morning turning into clear mucus during the day. The patient reported in July that he was able to get off of oxygen completely. 

In August 2018, the patient reported still breathing stronger while finding himself using oxygen occasionally when the weather in Southern California is affected by the humidity or the recent fires. However, overall, the patient reports seeing benefits and improvement from his symptoms related to Pulmonary Fibrosis. 

Case 3: Improvement of Oxygen Saturation 

A 61-year-old male with severe pulmonary fibrosis and COPD suffered from shortness of breath, tight chest, wheezing, coughing blood, cough, difficulty breathing, and oxygen saturation of 80 upon exertion. Dr. recommended ClearLung from Wei Laboratories for a lung bacterial infection. After 1 week, the coughing had decreased but his oxygen saturation was taking a long time to rise. Dr. then recommended adding the Soup A, Soup B and LC Balancer. After 1 additional week, his oxygen levels were measured at 95. Before treatment, he had trouble getting his oxygen levels to 90 with 6 months of strict nutritional therapy and diet. 

Case 4: Elimination of Oxygen Usage in IPF Patient  

A 65-year-old female diagnosed with pulmonary fibrosis came for therapy in 2005. Her pulmonologist had identified the state of the disease as being terminal. He had anticipated her remaining life time to be about 2 years. She had to use an oxygen tank to facilitate her breathing. 

Dr. prescribed a combined treatment composed of acupuncture and herbal remedies from Wei Laboratories including Soup A, Soup B, and LC Balancer for a total length of 3 months. The results have been remarkable. She did not have to use her oxygen tank anymore and was able to exercise again (e.g. playing tennis). She did really well and the results have sustained for 6 years. 

Case 5: Return of Daily Activities after IPF Program 

An 86-year-old man had been diagnosed with life threatening pulmonary fibrosis from orchard spray and toxic waste from industrial plants. As all health care providers understand, Pulmonary Fibrosis has two main causes and either one is virtually a lock on a death sentence. The two causes both destroy so much lung tissue there is no way to pass oxygen to the tissues of the body and death ensues. It is a rapid downward spiral. The two main causes are external and internal. The external is anything toxic that can destroy the lung tissue at the alveolar level such as pesticides, industrial gaseous by products, etc. The internal cause which I might add is extremely common is 

GERD (gastric esophageal reflux disease). This problem causes stomach acid (HCL) at night to be allowed to go into the lung tissue, thus destroying it. 

This gentleman also had hypertension and high fat content in the blood. I instituted a heavy metal chelating regime and put him on the Wei Laboratories protocol for pulmonary fibrosis with Soup A, Soup B and LC Balancer. Within 3 months the patient, who could hardly walk into my clinic, was playing 18 holes of golf, volunteering as a mailman, and taking care of his rental property as well as doing landscaping and maintenance work. 5 years later he is doing the same. 

Case 6: Successful Resolution of Pulmonary Fibrosis 

A male patient, around 70 years old, had been diagnosed with pulmonary fibrosis. The patient identified himself as an active man who liked to exercise (e.g. hiking). Dr. applied a program including Soup A, Soup B, and LC Balancer from Wei Laboratories for a total length of 3 months. The treatment yielded perfect results. Upon completing the herbal program, the patient was able to hike 9 miles without any resting period (before he had to stop every 100ft). The old strength has been restored and the results have been sustained. 

Case 7: Reduction of Symptoms of Idiopathic Pulmonary Fibrosis and Chronic Fatigue  

A female patient presented to the Center on September 13th, 2017 after being diagnosed with Idiopathic Pulmonary Fibrosis with symptoms of shortness of breath, low energy, constipation, and acid reflux. She was diagnosed with mixed connective tissue disease with Raynauds phenomenon manifesting symptoms of cold hands and feet. She had difficulty gaining weight due to a severe lack of appetite. Her primary care physician had prescribed her Aspirin, Ativan, Tylenol, Claritin, Mucinex, Flonase, and Vitanol primarily for mucus congestion. 

The doctor requested the patient complete a comprehensive blood analysis. The findings revealed the patient is anemic and had possible internal bleeding in the gut. It showed that she had dysbiosis in the gut possibly due to an infection based on a B12, Folate, B5 and Iron deficiency. Her blood cells are too large, leading to an inability to deliver oxygen properly based on her MCV levels. Her neutrophils and monocytes were very high, indicating that she has a bacterial invasion. Her sodium and calcium levels were low, as were her BUN levels, indicating possible adrenal and kidney dysfunction. Her albumin was also low indicating the patient may have liver, bile duct, and gallbladder congestion. The result showed parathyroid and endocrine dysfunction possibly due to an overload of heavy metals. 

The doctor developed a treatment plan to address the liver, kidney, GI, and lung-related problems to help improve energy, shortness of breath, and digestive problems. The doctor recommended the patient begin Wei Laboratories protocol which consisted of Soup A to help restore the lung structure, Soup B to help break down scar tissue in the lungs, LC Balancer to enhance kidney function, Brown to support the liver in detoxification, Levera to help remove buildup of toxins due to liver inflammation and KS to help reduce kidney inflammation. In addition, she was recommended to take Probiosis to reduce stomach and intestinal inflammation, PA to reduce inflammation in the pancreas and relieve her constipation, SJ to help repair stomach lining, Spring Capsule to restore proper stomach acidity to resolve acid reflux, and Formula B to promote proper gastric empty. The doctor also recommended that the patient support the Wei Laboratories protocol with digestive enzymes and a low-carb diet rich in protein and fat. 

On September 24th, the patient reported that her hands and feet were not getting as cold anymore. Her hands would previously turn white from being so cold and now would seldom turn white. No other improvements were reported at that time. On October 3rd, the patient had reported her overall breathing had improved. She was sleeping better, was more alert during the day and no longer had stomach pain. Her coughing episodes were substantially reduced and her breathing at rest was not labored anymore. The patient did mention that she had been experiencing anxiety and depression, especially before bedtime. The doctor recommended her to start taking Wei Laboratories Calm formula 1 capsule 3x a day with an addition 2 capsules before bed. 

On October 8th, the patient reported having fewer episodes of anxiety and depression. She described feeling 180 degrees different and started to make plans to go outside. The coughing had subsided completely with significantly improved breathing. The patient did note that she was having some edema and swelling in the legs in which the doctor suggested her to add in Java formula to support lymphatic drainage. 

On October 19th, the patient reported finally gaining weight. Her breathing was no longer a nuisance and had allowed her to go grocery shopping with her daughter over the weekend. Although her energy levels were much higher, the patient noticed that she still felt very fatigued at times throughout the day. There was a pattern of having good energy levels until the afternoon. She even had an episode with nausea and threw up. Even though the liver health should be much better at this point, the doctor felt that there may be other gram-negative bacteria in the liver and recommended adding Wei Laboratories Bilegen, L-2, and L-3 formulas to further strengthen liver immunity and clear the liver infection by the gram-negative bacteria. The doctor also thought that there may be fungus in the liver and pancreas and a parasite in the bile duct and advised her to start taking Glymycin, Glymycin-R, Levera-R, and Paramin-R to reduce congestion of the liver and pancreas due to infections related to fungus and/or parasites. 

After adding the additional liver support and infection clearing products, the patient reported exercising for 15 minutes in the morning and evening on November 2nd. Her energy levels have increased tremendously and she was ready to begin gym exercises. On November 14th, the patient noticed she was only experiencing coughing when she drinks cold temperature drinks due to it creating spasms because of her mixed connective tissue disease. The doctor recommended only consuming room temperature drinks. The doctor also increased her Vitamin C intake to 3000 mg per day. For the first time in 2 years, she now feels her energy is stable and has talked with her family to buy a car and start driving again. 

Improvement of IPF with Natural Products 

A 69-year-old male presented with severe shortness of breath (rated 7/10), coughing (7/10) and low energy levels (5/10). He had a long history of smoking (40 years) and was also exposed to asbestos. In 2015, he was diagnosed with asbestosis that progressed to histoplasmosis and eventually lead to his current diagnosis of idiopathic pulmonary fibrosis (IPF). He was diagnosed via chest X-ray and also had spirometry testing done where they found his lung function was at 59% in August of 2015. He was placed on OFEV by his doctor to prevent further hardening of the lungs. After 15 months of being on that medication he felt no improvement, so he sought out help from Dr.  in December of 2016. 

In his initial consult, the patient mentioned he could not walk one block (or walk up 14 stairs) without having to stop and rest for 3 minutes to catch his breath. He was also on oxygen 7 days a week at this point (but not every hour of the day). Dr.  preformed spirometry testing which indicated his forced expiratory volume (FVC) was at 48%. His forced expiratory flow rate between 25-75% (FEF2575) was 62%. This exam takes into account the involvement with allergens to see the relationship between allergic predictors and Small Airway Disease (SAD), this is the reason that Dr.  recommends food sensitivity testing to see how food allergens affect airway health. His resting oximetry without oxygen was 66.1% and his resting pulse was 90.9 bpm. As previously stated, he went through food sensitivity testing, which identified many abnormal food sensitivity reactions, which negatively impacted and contributed to his difficulty breathing. Nutritional testing was completed and identified nutritional deficiencies in Omega-3 fatty acids, Vitamin A and Vitamin D, that weakened his overall lung and body health. Nutrient deficiencies, when present, identified, and corrected will accelerate healing and recovery time. Dr. recommended using Wei Laboratories herbal formulas consisting of Soup A, Soup B and LC Balancer liquid at full dose, along with dietary supplements and a nutritional plan. 

After 8 weeks of using Wei products, following dietary guidelines given by the practitioner consisting of: food elimination plan and vitamin therapy (vitamin D), he also exercised 30 minutes daily and made a conscious effort to 

hydrate his body, he noticed significant change in his quality of life. He could walk up 21 steps (33% more steps) without having to rest at the top. He also mentioned that his energy had gone from a 5 to a 7 out of 10. His shortness of breath and coughing had decreased from a 7 to a 4/10. He was also able to walk without stopping to 

catch his breath, even without the use of oxygen. His oxygen dependence went from using it 7 days a week to using it just 3 days a week. 

He was retested at the end of January 2017 for his spirometry and oximetry results. His spirometry showed his FVC increased to 55% (from 48%) and his FEF2575 increased to 67% (from 62%). His resting oximetry without oxygen increased to an average of 95.8% (from 66.1%). His resting pulse decreased dramatically to 63.1 bpm from 90.9 bpm. 

The patient had improvement with each symptom and felt like a new man from this treatment. He was able to be more mobile and use less oxygen, which ultimately changed his life. He continued products for 4 months due to the results he continued to see. 

Test Results Before Treatment 

Test Results After Treatment 

Are your customers raving about you on social media? Share their great stories to help turn potential customers into loyal ones.